Publication:
Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)

Thumbnail Image
Files
s12094-009-0390-2.pdf(254.3 KB)
Date
2009-07
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Sánchez Henarejos, Pilar ; Ros Martínez, Silverio ; Marín Zafra, Gema R. ; Alonso-Romero, José Luis ; Navarrete Montoya, Agustín
item.page.secondaryauthor
item.page.director
Publisher
Springer
publication.page.editor
publication.page.department
Medicina
DOI
https://doi.org/10.1007/s12094-009-0390-2
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Pegylated liposomal doxorubicin (PLD) is a drug whose use is increasingly common. It has been associated with a lower rate of haematologic and cardiac side effects than its nonencapsulated form. However, mucocutaneous toxicity is quite frequent and can be severe. Here we provide a case report of a patient who developed an intertrigolike eruption during treatment with PLD.
publication.page.subject
Liposomes , Anthracyclines , Breast carcinoma , Dermatologic toxicity
Citation
Clin Transl Oncol (2009) 11:486-487
URI
http://hdl.handle.net/10201/146094
item.page.embargo
Collections
Artículos
Ir a Estadísticas